Skip to content

Clinical trials

Phase 2 Heart Failure trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: Poland Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20093
20103
20112
20123
20134
20143
20162
20174
20181
20191
20203
20212
20222
20235
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated9
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer11
AstraZeneca4
Bristol-Myers Squibb4
Novartis Pharmaceuticals4
Cardurion Pharmaceuticals, Inc.2
Novo Nordisk A/S2
Pfizer2
ARCA Biopharma, Inc.1
Akros Pharma Inc.1
AskBio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure47
Cardiovascular Diseases5
Heart Diseases3
Cardiomegaly2
Diabetes Mellitus, Type 22
Hyperkalemia2
Myocardial Infarction2
Renal Insufficiency, Chronic2
Atrial Fibrillation1
Atrial Flutter1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.